The survey found that 41% of those diagnosed with depression and/or anxiety and who are currently taking a mental health medication think it feels “one-size-fits-all” and 74% of those who are still finding a medication that works for them say that mental health treatment feels “one-size-fits-all.”
The GeneSight Mental Health Monitor is a nationwide survey conducted online by ACUPOLL Precision Research, Inc. between February 23 — March 6, 2026, among a representative sample (n=1002) of U.S. adults age 18+. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 4%. A nationally representative sample of adults aged 18 years or older was recruited and balanced to match U.S. Census quotas across five primary metrics (i.e., age, gender, income, education and ethnicity). In addition to the nationally representative sample, a statistically reliable sample was achieved of respondents who were self-reported as being diagnosed by a medical professional with depression or anxiety. ACUPOLL has more than 30 years of experience conducting statistically valid research through careful recruiting and quality control measures.